These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10702199)

  • 1. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.
    Shirvani VN; Ouatu-Lascar R; Kaur BS; Omary MB; Triadafilopoulos G
    Gastroenterology; 2000 Mar; 118(3):487-96. PubMed ID: 10702199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
    Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
    J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
    Morris CD; Armstrong GR; Bigley G; Green H; Attwood SE
    Am J Gastroenterol; 2001 Apr; 96(4):990-6. PubMed ID: 11316217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma.
    Lagorce C; Paraf F; Vidaud D; Couvelard A; Wendum D; Martin A; Fléjou JF
    Histopathology; 2003 May; 42(5):457-65. PubMed ID: 12713622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids.
    Zhang F; Altorki NK; Wu YC; Soslow RA; Subbaramaiah K; Dannenberg AJ
    Gastroenterology; 2001 Dec; 121(6):1391-9. PubMed ID: 11729118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus.
    Kaur BS; Khamnehei N; Iravani M; Namburu SS; Lin O; Triadafilopoulos G
    Gastroenterology; 2002 Jul; 123(1):60-7. PubMed ID: 12105834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.
    Wilson KT; Fu S; Ramanujam KS; Meltzer SJ
    Cancer Res; 1998 Jul; 58(14):2929-34. PubMed ID: 9679948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 inhibition in esophagitis, Barrett's esophagus and esophageal cancer.
    Piazuelo E; Jimenez P; Lanas A
    Curr Pharm Des; 2003; 9(27):2267-80. PubMed ID: 14552327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Brabender J; Lord RV; Wickramasinghe K; Metzger R; Schneider PM; Park JM; Hölscher AH; DeMeester TR; Danenberg KD; Danenberg PV
    J Gastrointest Surg; 2002; 6(3):359-67. PubMed ID: 12022988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells.
    Souza RF; Shewmake K; Pearson S; Sarosi GA; Feagins LA; Ramirez RD; Terada LS; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G743-8. PubMed ID: 15231484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 expression in Barrett's esophagus.
    Kandil HM; Tanner G; Smalley W; Halter S; Radhika A; Dubois RN
    Dig Dis Sci; 2001 Apr; 46(4):785-9. PubMed ID: 11330414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
    Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
    World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression and cell proliferation are increased in MUC2-positive area of columnar-lined esophagus.
    Jang TJ; Cho MY
    Pathol Int; 2005 Sep; 55(9):546-9. PubMed ID: 16143029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of glutathione s-transferase-pi in Barrett's metaplasia and Barrett's adenocarcinoma cell lines.
    Compton KR; Orringer MB; Beer DG
    Mol Carcinog; 1999 Feb; 24(2):128-36. PubMed ID: 10078940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
    J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.
    van der Woude CJ; Jansen PL; Tiebosch AT; Beuving A; Homan M; Kleibeuker JH; Moshage H
    Hum Pathol; 2002 Jul; 33(7):686-92. PubMed ID: 12196918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.